Serveur d'exploration H2N2 - Exploration (Accueil)

Index « Keywords » - entrée « Vaccination »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
VSV < Vaccination < Vaccination (adverse effects)  Facettes :

List of bibliographic references indexed by Vaccination

Number of relevant bibliographic references: 44.
Ident.Authors (with country if any)Title
000125 (2018-04) Tomi Sarkanen ; Anniina P. E. Alakuijala ; Yves Dauvilliers [France] ; Markku PartinenIncidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis
000128 (2018-03) V. Busignies [France] ; G. Simon [France] ; G. Mollereau [France] ; O. Bourry [France] ; V. Mazel [France] ; Manuel Rosa-Calatrava [France] ; P. Tchoreloff [France]Development and pre-clinical evaluation in the swine model of a mucosal vaccine tablet for human influenza viruses: A proof-of-concept study
000160 (2018) Daniil A. Korenkov [Russie] ; Karen L. Laurie [Australie] ; Patrick C. Reading [Australie] ; Louise A. Carolan [Australie] ; Kok Fei Chan [Australie] ; Irina I. Isakova-Sivak [Russie] ; Tatiana A. Smolonogina [Russie] ; Kanta Subbarao [Australie] ; Ian G. Barr [Australie] ; Julie Villanueva [États-Unis] ; Svetlana Shcherbik [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa G. Rudenko [Russie]Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.
000220 (2018) Guo Luo ; Aditya Ambati ; Ling Lin ; Mélodie Bonvalet ; Markku Partinen [Finlande] ; Xuhuai Ji ; Holden Terry Maecker ; Emmanuel Jean-Marie MignotAutoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy
000377 (2016-07) Stéphanie Fougerolle [France] ; Loïc Legrand [France] ; Dion Garrett [Royaume-Uni] ; Ilhan Birand [Royaume-Uni] ; Marc Foursin [France] ; Xavier D Blon [France] ; Pierre Bayssat [France] ; Richard Newton [Royaume-Uni] ; Stéphane Pronost [France] ; Romain Paillot [Royaume-Uni]Influential factors inducing suboptimal humoral response to vector-based influenza immunisation in Thoroughbred foals
000389 (2016) Paul Loubet [France] ; Nezha Samih-Lenzi [France] ; Florence Galtier [France] ; Philippe Vanhems [France] ; Pierre Loulergue [France] ; Xavier Duval [France] ; Stéphane Jouneau [France] ; Déborah Postil [France] ; Sylvie Rogez [France] ; Martine Valette [France] ; Corinne Merle [France] ; Corinne Régis [France] ; Yolande Costa [France] ; Zineb Lesieur [France] ; Pierre Tattevin [France] ; Bruno Lina [France] ; Fabrice Carrat [France] ; Odile Launay [France]Factors associated with poor outcomes among adults hospitalised for influenza in France: A three-year prospective multicenter study
000963 (2013) M. Panning [Allemagne]Influenza heute und in Zukunft
000A85 (2012) Kawsar R. Talaat ; Ruth A. Karron ; Philana H. Liang ; Bridget A. Mcmahon ; Catherine J. Luke ; Bhagvanji Thumar ; Grace L. Chen ; Ji-Young Min ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; George W. Kemble ; Kanta SubbaraoAn open‐label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults
000B97 (2011) Guus F. Rimmelzwaan [Pays-Bas] ; Rogier Bodewes ; Albert D M E. OsterhausVaccination strategies to protect children against seasonal and pandemic influenza.
000D93 (2010) N A Mazurkova ; N N Ryndiuk ; L N Shishkina ; V A Ternovo ; Iu V. Tumanov ; L E Bulychev ; M O Skarnovich ; A S Kabanov ; S G Panchenko ; R P Ale Nikov ; T N Il'Ina ; V I Kuzubov ; S Ia Mel'Nikov ; A N Mironov ; S A Korovkin ; A N Sergeev ; I G Drozdov[Results of clinical trials on reactogenicity, safety, and immunogenicity of influenza allantoic intranasal live vaccine "Ultragrivac" (type A/H5N2)].
000E67 (2010) Chih-Jen Wei [États-Unis] ; Jeffrey C. Boyington ; Patrick M. Mctamney ; Wing-Pui Kong ; Melissa B. Pearce ; Ling Xu ; Hanne Andersen ; Srinivas Rao ; Terrence M. Tumpey ; Zhi-Yong Yang ; Gary J. NabelInduction of broadly neutralizing H1N1 influenza antibodies by vaccination.
001087 (2009) Shufang Fan [République populaire de Chine] ; Yuwei Gao ; Kyoko Shinya ; Chris Kafai Li ; Yanbing Li ; Jianzhong Shi ; Yongping Jiang ; Yongbing Suo ; Tiegang Tong ; Gongxun Zhong ; Jiasheng Song ; Ying Zhang ; Guobin Tian ; Yuntao Guan ; Xiao-Ning Xu ; Zhigao Bu ; Yoshihiro Kawaoka [États-Unis] ; Hualan ChenImmunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates.
001243 (2008) R J Green [Afrique du Sud] ; C. Feldman ; B. Schoub ; G A Richards ; S A Madhi ; H J Zar ; U. Lalloo ; K. Klugman ; D. Phillips ; N A Cameron ; R R EggersInfluenza guideline for South Africa--update 2008.
001653 (2004) Thomas Palker [États-Unis] ; Irina Kiseleva ; Kimberly Johnston ; Qin Su ; Timothy Toner ; Christopher Szymkowiak ; Wan-Sang Kwan ; Boris Rubin ; Luba Petrukhin ; Joan Wlochowski ; Juanita Monteiro ; Nikolai Kraiouchkine ; Daniel Distefano ; Larisa Rudenko ; Alan Shaw ; Rima YouilProtective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
001795 (2002) Yu. A. Desheva ; G. V. Danini ; E. P. Grigoryeva ; S. A. Donina ; I. V. Kiseleva ; A. R. Rekstin ; L. A. Ermakova ; V. K. Natsina ; V. M. Nikolaeva ; N. I. Lonskaya ; G. A. Elshina ; V. G. Zhavoronkov ; V. P. Drinevsky ; M. K. Erofeeva ; A. N. Naikhin ; L. G. RudenkoEn Russe
001872 (2001) M. D. Wareing [Australie] ; J. M. Watson [Australie] ; M. J. Brooks [Australie] ; G. A. Tannock [Australie]Immunogenic and isotype‐specific responses to russian and US cold‐adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice
001B22 (1997) K. Hashigucci ; S. Tamura ; T. Kurata ; H. Kamiya ; T. Ishidate[Efficacy of nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin in healthy volunteers].
001D27 (1995) M. Aymard [France] ; M. F. Odelin [France] ; J. Million-Jolly [France]Immunité antigrippale
001D60 (1995) Marco Salvetti [Italie] ; Angela Pisani [Italie] ; Stefano Bastianello [Italie] ; Enrico Millefiorini [Italie] ; Carla Buttinelli [Italie] ; Carlo Pozzilli [Italie]Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination
001E68 (1993) Louis F. Fries [États-Unis] ; Susan B. Dillon [États-Unis] ; James E. K. Hildreth [États-Unis] ; Ruth A. Karron [États-Unis] ; Ann W. Funkhouser [États-Unis] ; Carl J. Friedman [États-Unis] ; Christopher S. Jones [États-Unis] ; Vasantha G. Culleton [États-Unis] ; Mary Lou Clements [États-Unis]Safety and Immunogenicity of a Recombinant Protein Influenza A Vaccine in Adult Human Volunteers and Protective Efficacy against Wild-Type H1N1 Virus Challenge
002128 (1990) I. N. Mbawuike ; H. R. Six ; T. R. Cate ; R. B. CouchVaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes
002225 (1988) A. N. Slepushkin [Russie] ; P. A. Patriarca [États-Unis] ; N. P. Obrosova-Serova [Russie] ; M. W. Harmon [États-Unis] ; L. N. Kupryashina [Russie] ; S. G. Cheshik [Russie] ; R. B. Vartanyan [Russie] ; G. I. Alexandrova [Russie] ; F. I. Polezhaev [Russie] ; N. I. Lonskaya [Russie] ; B. V. Yagodovskii [Russie] ; A. P. Kendal [États-Unis] ; V. M. Zhdanov [Russie]Class-specific antibody responses in school children vaccinated with an A/Brazil/11/78 (H1N1)-like recombinant influenza virus prepared from the A/Leningrad/134/57 paediatric cold-adapted donor strain
002352 (1986) Tadao Sonoguchi [Japon] ; Mitsuo Sakoh [Japon] ; Nobuharu Kunita [Japon] ; Kiyoaki Satsuta [Japon] ; Hideo Noriki [Japon] ; Hideo Fukumi [Japon]Reinfection with Influenza A (H2N2, H3N2, and H1N1) Viruses in Soldiers and Students in Japan
002496 (1984) W. Graeme Laver [République populaire de Chine] ; Robert G. Webster [République populaire de Chine] ; C. M. Chu [République populaire de Chine]Summary of a Meeting on the Origin of Pandemic Influenza Viruses
002498 (1984) N. Yamane [Japon] ; Y. Nakamura [Japon] ; M. Yuki [Japon] ; T. Odagiri [Japon] ; N. Ishida [Japon]Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers
002552 (1984) R. B. Belshe ; L. P. Van Voris ; J. Bartram ; F. K. CrookshanksLive attenuated influenza A virus vaccines in children: results of a field trial
002567 (1983) M L Clements ; S. O'Donnell ; M M Levine ; R M Chanock ; B R MurphyDose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.
002614 (1983) C. W. Potter [Royaume-Uni] ; R. Jennings [Royaume-Uni] ; A. Clark [Royaume-Uni] ; M. Ali [Royaume-Uni]Interference following dual inoculation with influenza A (H3N2) and (H1N1) viruses in ferrets and volunteers
002709 (1981) Y Z Ghendon ; A I Klimov ; G I Alexandrova ; F I PolezhaevAnalysis of genome composition and reactogenicity of recombinants of cold-adapted and virulent virus strains.
002822 (1980) J. Drescher [Allemagne] ; U. Desselberger [Allemagne]Comparison of the antineuraminidase antibody response to vaccination with intact virus and subunit preparations obtained by different techniques of the influenza virus strains A/Sing/1/57 (H2N2), A/Hong Kong/1/68 (H3N2) and A/Port Chalmers/1/73 (H3N2)
002859 (1980) J. Drescher [Allemagne] ; U. Desselberger [Allemagne]Antineuraminidase antibody response to vaccination of chickens with intact virus and different subunit preparations of the influenza virus strains A/Sing/1/57 (H2N2), A/Hong Kong/1/68 (H3N2) and A/Port Chalmers/1/73 (H3N2)
002A78 (1977) Gary R. Noble [Géorgie (pays), États-Unis] ; Harold S. Kaye [Géorgie (pays)] ; Alan P. Kendal [Géorgie (pays)] ; Walter R. Dowdle [Géorgie (pays)]Age-Related Heterologous Antibody Responses to Influenza Virus Vaccination
002A91 (1977) U. Desselberger [Allemagne]Preparation-conditioned changes of the antigenicity of influenza virus neuraminidases
002B11 (1976) B. Dolezalová ; E. Tu Ková ; M. Stárek ; V. Vonka ; H. ZavadovaAbility of temperature-sensitive mutants of the recombinant influenza S/N (H2N1) virus to induce immunity to parental (H0N1 and H2N2) viruses.
002B64 (1975) E. Reichert ; R. MaulerEffect of neuraminidase on potency of inactivated influenza virus vaccines in mice.
002B99 (1974) M. Alexandrescu ; L. Handrache ; V. Moro Anu ; G. Vancea ; L. Ionescu ; A. ColevInfluenza viruses and lympho-macrophagic cells. I. In vitro interaction between influenza A2-59 virus (H2N2) and peritoneal macrophagic cells from normal or immunized mice and rats.
002D78 (????) Iu A. Desheva ; G V Danini ; E P Grigor'Eva ; S A Donina ; I V Kiseleva ; A R Rekstin ; L A Ermakova ; V K Natsina ; V M Nikolaeva ; N I Lonskaia ; G A El'Shina ; V G Zhavoronkov ; V P Drinevski ; M K Erofeeva ; A N Na Khin ; L G Rudenko[The investigation of the safety, genetic stability and immunogenicity of live influenza vaccine for adults in vaccination of 3-6 years old children].
002D79 (????) Iu A. Desheva ; Kh Lu ; A R Rekstin ; D M Kats ; L G Rudenko ; A I Klimov[The inoculative properties of cold-adapted reassortant A(H5N2) influenza strain during intranasal administration to mice].
002D80 (????) E Iu Boravleva ; N F Lomakina ; E A Kropotkina ; I A Rudneva ; S S Iamnikova ; L G Rudenko ; V V Drygin ; A S Gambarian[The generation and characteristics of reassortant influenza A virus with H5 hemagglutinin and other genes from the apathogenic virus H6N2].
002D84 (????) E P Grigor'Eva ; Iu A. Desheva ; S A Donina ; A N Na Khin ; A R Rekstin ; I B Barantseva ; E A Zavitkova ; T M Moskvicheva ; V G Zhavoronkov ; L G Rudenko[The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years].
002E11 (????) L A Stepanova ; A A Kovaleva ; M V Potapchuk ; A V Korotkov ; V V Kupriianov ; E A Blokhina ; R Iu Kotliarov ; L M Tsybalova[Immunogenicity of recombinant proteins including ectodomain of M2 influenza virus A].
002E24 (????) I V Kiseleva ; A I Klimov ; E P Grigor'Eva ; N V Larionova ; G I Aleksandrova ; L G Rudenko[Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains].
002E26 (????) T A Smolonogina ; Iu A. Desheva ; A R Rekstin ; A N Mironov ; L G Rudenko[Evaluation of the anti-neuraminidase antibodies in clinical trials of the live influenza vaccine of the A(H5N2) subtype].
002E38 (????) O S Kashirina ; M I Chernikova ; Yu M. Vasiliev[COMPARATIVE STUDY OF IMMUNOGENICITY AND PROTECTIVE EFFECT OF LIVE COLD-ADAPTED AND INACTIVATED VACCINES AGAINST TYPE A INFLUENZA].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Vaccination" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Vaccination" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Vaccination
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021